The company maintains a conservative capital structure with a debt-to-equity ratio of 0.32 and has bolstered liquidity, as cash and equivalents have surged to $97.9 million, providing a stable foundation for its turnaround efforts.
InnovAge Holding Corp. (INNV) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 |
|---|
| Total Current Assets | 214.31M | 176.11M | 173.14M | 173.14M | 240.96M | 250.93M | 166.93M | 119.45M |
| Cash & Short-Term Investments | 141.33M | 105.92M | 102.79M | 102.78M | 184.45M | 203.7M | 114.56M | 61.2M |
| Cash Only | 97.89M | 64.14M | 56.96M | 56.95M | 184.45M | 203.7M | 114.56M | 61.2M |
| Short-Term Investments | 43.44M | 41.77M | 45.83M | 45.83M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 45.67M | 39.68M | 51.43M | 51.43M | 42.67M | 37.98M | 48.05M | 55.01M |
| Days Sales Outstanding | 11.56 | 16.97 | 24.58 | 27.28 | 22.29 | 21.74 | 30.92 | 43.12 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 10K | 6.04M | 0 | 14K | 0 | 0 | 4.31M | 3.25M |
| Total Non-Current Assets | 343.08M | 381.12M | 406.69M | 374.52M | 321.92M | 287.68M | 242.7M | 243.78M |
| Property, Plant & Equipment | 187.5M | 194.94M | 221.44M | 221.44M | 176.26M | 142.72M | 102.49M | 101.19M |
| Fixed Asset Turnover | 5.22x | 4.38x | 3.45x | 3.11x | 3.96x | 4.47x | 5.53x | 4.60x |
| Goodwill | 142.05M | 0 | 139.95M | 139.95M | 124.22M | 124.22M | 116.14M | 117.27M |
| Intangible Assets | 3.22M | 145.92M | 4.54M | 4.54M | 5.86M | 6.52M | 5.18M | 5.84M |
| Long-Term Investments | 0 | 2.2M | 5.45M | 2.65M | 5.49M | 3.49M | 15.89M | 15.43M |
| Other Non-Current Assets | 10.32M | 7.67M | 1.71M | 5.95M | 3.47M | 4.54M | 3M | 4.07M |
| Total Assets | 557.39M | 557.23M | 579.84M | 547.66M | 562.87M | 538.61M | 409.63M | 363.23M |
| Asset Turnover | 1.85x | 1.53x | 1.32x | 1.26x | 1.24x | 1.18x | 1.38x | 1.28x |
| Asset Growth % | -0.77% | -3.9% | 5.87% | -2.7% | 4.5% | 31.49% | 12.77% | - |
| Total Current Liabilities | 203.89M | 164.81M | 138.6M | 138.6M | 105.31M | 78.56M | 76.63M | 83.46M |
| Accounts Payable | 115.36M | 76.75M | 55.46M | 55.46M | 50.56M | 32.36M | 28.88M | 30.35M |
| Days Payables Outstanding | 34.8 | 104.18 | 32.04 | 34.5 | 32.76 | 24.81 | 24.75 | 31.21 |
| Short-Term Debt | 13.4M | 12.17M | 12.54M | 3.79M | 7.16M | 5.87M | 3.43M | 3.63M |
| Deferred Revenue (Current) | 275K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 75.13M | 75.89M | 70.6M | 55.4M | 47.58M | 40.34M | 44.32M | 49.48M |
| Current Ratio | 1.05x | 1.07x | 1.25x | 1.25x | 2.29x | 3.19x | 2.18x | 1.43x |
| Quick Ratio | 1.05x | 1.07x | 1.25x | 1.25x | 2.29x | 3.19x | 2.18x | 1.43x |
| Cash Conversion Cycle | -23.24 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 84.73M | 129.51M | 141.43M | 109.25M | 103.82M | 102.08M | 225.25M | 198.33M |
| Long-Term Debt | 45.52M | 57.46M | 61.48M | 61.48M | 68.21M | 71.57M | 210.43M | 186.82M |
| Capital Lease Obligations | 84.2M | 31.45M | 39.02M | 39.02M | 9.44M | 5.19M | 4.09M | 4.33M |
| Deferred Tax Liabilities | 36.61M | 39.14M | 39.63M | 7.46M | 25.04M | 22.56M | 9.28M | 6.11M |
| Other Non-Current Liabilities | 2.13M | 1.46M | 1.3M | 1.3M | 1.13M | 2.76M | 1.45M | 1.08M |
| Total Liabilities | 288.62M | 294.32M | 280.03M | 247.85M | 209.13M | 180.65M | 301.88M | 281.79M |
| Total Debt | 86.95M | 101.08M | 113.03M | 113.03M | 84.81M | 82.63M | 217.96M | 194.78M |
| Net Debt | -10.94M | 36.94M | 56.08M | 56.09M | -99.64M | -121.07M | 103.39M | 133.58M |
| Debt / Equity | 0.32x | 0.38x | 0.38x | 0.38x | 0.24x | 0.23x | 2.02x | 2.39x |
| Debt / EBITDA | 2.78x | - | - | - | 8.91x | 0.95x | 3.50x | 4.00x |
| Net Debt / EBITDA | -0.35x | - | - | - | -10.47x | -1.39x | 1.66x | 2.74x |
| Interest Coverage | 18.10x | -3.50x | -4.42x | -32.37x | -1.87x | -1.08x | 3.44x | 3.85x |
| Total Equity | 268.78M | 262.91M | 299.81M | 299.81M | 353.74M | 357.96M | 107.75M | 81.44M |
| Equity Growth % | -2.31% | -12.31% | 0% | -15.25% | -1.18% | 232.22% | 32.3% | - |
| Book Value per Share | 1.96 | 1.94 | 2.21 | 2.21 | 2.61 | 2.64 | 0.81 | 0.61 |
| Total Shareholders' Equity | 235.6M | 234.97M | 269.26M | 269.26M | 332.36M | 334.56M | 101.02M | 74.19M |
| Common Stock | 137K | 137K | 137K | 136K | 136K | 136K | 133K | 133K |
| Retained Earnings | -105.76M | -101.05M | -68.31M | -68.31M | 4.73M | 10.66M | 64.74M | 38.46M |
| Treasury Stock | -7.5M | -7.5M | -179K | -179K | 0 | 0 | -193K | -193K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 33.17M | 27.94M | 30.55M | 30.55M | 21.38M | 23.41M | 6.74M | 7.25M |
Quick answers to the most common questions about buying INNV stock.
As of 2025, InnovAge Holding Corp. (INNV) had total assets of $557.2M including $176.1M in current assets.
InnovAge Holding Corp. (INNV) carries total debt of $101.1M, offset by $105.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
InnovAge Holding Corp. (INNV) has total shareholders' equity (book value) of $235.0M ($1.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.
InnovAge Holding Corp. (INNV) reported a current ratio of 1.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill impairment risk
Metrics are mathematically derived from official filings.
Asset Base Contractions Mask Operational Shift
InnovAge's total assets have declined from $579.8M in 2024Q4 to $557.4M in 2026Q4, a 3.9% reduction, despite revenue acceleration, suggesting a strategic simplification of the balance sheet away from expansionary capital.
The asset contraction appears driven by a net reduction in total liabilities and a decline in property, plant, and equipment, which fell from $221.4M to $187.5M over the period. This trend may indicate a pause in new center construction or a shift toward optimizing existing sites rather than pursuing asset-heavy geographic expansion, consistent with a post-sanction recovery phase focused on stabilization.
Low Leverage Provides Strategic Flexibility
As of 2026Q4, InnovAge's debt-to-equity ratio stands at a conservative 0.32, based on $87.0M in total debt against $235.6M in equity, providing ample capacity for strategic investments or to absorb potential operational setbacks.
The debt load has fluctuated but remains modest relative to equity, suggesting the company is not reliant on leverage for growth. The recent increase from $38.4M in 2026Q3 to $87.0M may indicate a deliberate draw on credit facilities to bolster cash reserves ahead of anticipated operational needs, a prudent move given the business's regulatory sensitivity.
PPE Decline Signals Capacity Utilization Phase
Net property, plant, and equipment has decreased by $33.9M, or 15.3%, since 2024Q4, while goodwill has remained stable at around $142M, suggesting the company's primary capital allocation is currently focused on service delivery within existing infrastructure.
The decline in PPE net value, likely due to depreciation outpacing new capital expenditures, aligns with a strategy of maximizing participant density in existing PACE centers to drive operating leverage. The static goodwill balance indicates no recent acquisition activity, focusing the balance sheet risk profile entirely on operational execution rather than integration or impairment of past deals.
Cash Surge Bolsters Operational Runway
Cash and cash equivalents have more than doubled since 2025Q1, reaching $97.9M in 2026Q4, and the current ratio has stabilized above 1.0, providing a significant liquidity buffer against the volatility inherent in medical cost reporting.
This cash accumulation, occurring alongside debt increases, appears to be a deliberate treasury strategy to ensure ample liquidity. The improved cash position significantly reduces near-term financial risk and provides the operational flexibility needed to manage potential IBNR reserve adjustments or temporary reimbursement delays common in capitated government contracts.
Persistent Deficits Reflect Turnaround Costs
Cumulative retained earnings remain deeply negative at -$105.8M as of 2026Q4, though the deficit has widened modestly over the last two quarters, indicating that recent operational improvements have not yet fully offset historical losses.
The negative retained earnings are a direct result of past losses incurred during the regulatory sanctions and operational scaling phases. The recent sequential deepening of this deficit, even as the company posts quarterly profits, suggests that one-time or non-cash charges may still be weighing on the equity base, warranting a closer look at the components of net income.
Static Goodwill Amid Operational Recovery
Goodwill has remained unchanged at approximately $142M for eight consecutive quarters, a significant figure representing over 25% of total assets, which poses a potential impairment risk if the turnaround in participant economics stalls.
In a business where value is heavily tied to the regulatory approval and local market dominance of each PACE center, a static goodwill balance implies that past acquisition premiums have not been reassessed. If the company fails to achieve sustained profitability and participant growth at existing centers, this intangible asset could come under scrutiny, potentially leading to a material non-cash charge that would further erode the already negative equity base.